ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,512, issued on Aug. 12, was assigned to JAZZ PHARMACEUTICALS RESEARCH UK Ltd. (Sittingbourne, Great Britain).
"Cannabidiol-type cannabinoid compound" was invented by Geoffrey Guy (Cambridge, Great Britain), Volker Knappertz (Cambridge, Great Britain), Benjamin Whalley (Cambridge, Great Britain) and Marie Woolley-Roberts (Cambridge, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a cannabidiol (CBD) type cannabinoid compound for use as a medicament. The CBD-type cannabinoid, 6-hydroxy cannabidiol (6-0 H CBD), is a metabolite of CBD. The cannabinoid can be produced by synthetic means and a method for the p...